Cargando…

Gene Expression Variability in Human Hepatic Drug Metabolizing Enzymes and Transporters

Interindividual variability in the expression of drug-metabolizing enzymes and transporters (DMETs) in human liver may contribute to interindividual differences in drug efficacy and adverse reactions. Published studies that analyzed variability in the expression of DMET genes were limited by sample...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Lun, Price, Elvin T., Chang, Ching-Wei, Li, Yan, Huang, Ying, Guo, Li-Wu, Guo, Yongli, Kaput, Jim, Shi, Leming, Ning, Baitang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3634068/ https://www.ncbi.nlm.nih.gov/pubmed/23637747 http://dx.doi.org/10.1371/journal.pone.0060368

Ejemplares similares

Sex Differences in the Expression of Drug-Metabolizing and Transporter Genes in Human Liver
por: Yang, Lun, et al.
Publicado: (2012)

Two new ArrayTrack libraries for personalized biomedical research
por: Xu, Joshua, et al.
Publicado: (2010)

Hepatic drug-metabolizing enzymes and drug transporters in Wilson’s disease patients with liver failure
por: Szeląg-Pieniek, Sylwia, et al.
Publicado: (2021)

Ancestors’ dietary patterns and environments could drive positive selection in genes involved in micronutrient metabolism—the case of cofactor transporters
por: Parolo, Silvia, et al.
Publicado: (2017)

Quantitative Proteomics of Hepatic Drug‐Metabolizing Enzymes and Transporters in Patients With Colorectal Cancer Metastasis
por: Vasilogianni, Areti‐Maria, et al.
Publicado: (2022)

Pharmacogenomics of drug metabolizing enzymes and transporters: implications for cancer therapy
por: Li, Jing, et al.
Publicado: (2011)

Mechanisms of promiscuity among drug metabolizing enzymes and drug transporters
por: Atkins, William M.
Publicado: (2019)

Liquid Biopsy Enables Quantification of the Abundance and Interindividual Variability of Hepatic Enzymes and Transporters
por: Achour, Brahim, et al.
Publicado: (2020)

Islatravir Is Not Expected to Be a Victim or Perpetrator of Drug-Drug Interactions via Major Drug-Metabolizing Enzymes or Transporters
por: Bleasby, Kelly, et al.
Publicado: (2021)

Application of genome analysis strategies in the clinical testing for pediatric diseases
por: Jin, Yaqiong, et al.
Publicado: (2018)

Adaptive evolution of multiple-variable exons and structural diversity of drug-metabolizing enzymes
por: Li, Can, et al.
Publicado: (2007)

Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine
por: Ahmed, Shabbir, et al.
Publicado: (2016)

Immunological Response as a Source to Variability in Drug Metabolism and Transport
por: Christensen, Hege, et al.
Publicado: (2012)

Pharmacogenetics of Carbamazepine and Valproate: Focus on Polymorphisms of Drug Metabolizing Enzymes and Transporters
por: Iannaccone, Teresa, et al.
Publicado: (2021)

Impact of quercetin-induced changes in drug-metabolizing enzyme and transporter expression on the pharmacokinetics of cyclosporine in rats
por: Liu, Yani, et al.
Publicado: (2016)

Suppression of CYP2C9 by MicroRNA hsa-miR-128-3p in Human Liver Cells and Association with Hepatocellular Carcinoma
por: Yu, Dianke, et al.
Publicado: (2015)

Hepatic Xenobiotic Metabolizing Enzyme and Transporter Gene Expression through the Life Stages of the Mouse
por: Lee, Janice S., et al.
Publicado: (2011)

The influence of genetic polymorphisms in drug metabolism enzymes and transporters on the pharmacokinetics of different fluvastatin formulations
por: Xiang, Qian, et al.
Publicado: (2020)

Drug Metabolizing Enzyme and Transporter Gene Variation, Nicotine Metabolism, Prospective Abstinence, and Cigarette Consumption
por: Bergen, Andrew W., et al.
Publicado: (2015)

DMET™ (Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine
por: Arbitrio, Mariamena, et al.
Publicado: (2016)

The Systems Biology of Drug Metabolizing Enzymes and Transporters: Relevance to Quantitative Systems Pharmacology
por: Nigam, Sanjay K., et al.
Publicado: (2020)

Polymorphism of Drug Transporters, Rather Than Metabolizing Enzymes, Conditions the Pharmacokinetics of Rasagiline
por: Zubiaur, Pablo, et al.
Publicado: (2022)

Inflammation is a major regulator of drug metabolizing enzymes and transporters: Consequences for the personalization of drug treatment
por: Stanke-Labesque, Françoise, et al.
Publicado: (2020)

Evaluation of Pharmacogenetics of Drug-Metabolizing Enzymes and Drug Efflux Transporter in Renal Transplants Receiving Immunosuppressants
por: Sridharan, Kannan, et al.
Publicado: (2022)

Protein Abundance of Drug Metabolizing Enzymes in Human Hepatitis C Livers
por: Drozdzik, Marek, et al.
Publicado: (2023)

Metabolic fate of fructose in human adipocytes: a targeted (13)C tracer fate association study
por: Varma, Vijayalakshmi, et al.
Publicado: (2014)

Translational genomics
por: Kussmann, Martin, et al.
Publicado: (2014)

Evaluation of drug-drug interaction of lusutrombopag, a thrombopoietin receptor agonist, via metabolic enzymes and transporters
por: Katsube, Takayuki, et al.
Publicado: (2020)

Quantitative Proteomics of Clinically Relevant Drug-Metabolizing Enzymes and Drug Transporters and Their Intercorrelations in the Human Small Intestine
por: Couto, Narciso, et al.
Publicado: (2020)

Non-uniformity of Changes in Drug-Metabolizing Enzymes and Transporters in Liver Cirrhosis: Implications for Drug Dosage Adjustment
por: El-Khateeb, Eman, et al.
Publicado: (2021)

Effect of Genetic Variations in Drug-Metabolizing Enzymes and Drug Transporters on the Pharmacokinetics of Rifamycins: A Systematic Review
por: Sileshi, Tesemma, et al.
Publicado: (2022)

Downregulation of drug transport and metabolism in mice bearing extra-hepatic malignancies
por: Sharma, R, et al.
Publicado: (2008)

Effects of chronic kidney disease and uremia on hepatic drug metabolism and transport
por: Yeung, Catherine K., et al.
Publicado: (2013)

Fructose Alters Intermediary Metabolism of Glucose in Human Adipocytes and Diverts Glucose to Serine Oxidation in the One–Carbon Cycle Energy Producing Pathway
por: Varma, Vijayalakshmi, et al.
Publicado: (2015)

Gene Expression and Protein Abundance of Hepatic Drug Metabolizing Enzymes in Liver Pathology
por: Drozdzik, Marek, et al.
Publicado: (2021)

Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)-Based Proteomics of Drug-Metabolizing Enzymes and Transporters
por: Li, Jiapeng, et al.
Publicado: (2020)

Cranberry Ingestion Modulated Drug Transporters and Metabolizing Enzymes: Gefitinib Used as a Probe Substrate in Rats
por: Yu, Chung-Ping, et al.
Publicado: (2022)

Single-Cell RNA-Seq Technologies and Related Computational Data Analysis
por: Chen, Geng, et al.
Publicado: (2019)

VARIDT 2.0: structural variability of drug transporter
por: Fu, Tingting, et al.
Publicado: (2021)

VARIDT 1.0: variability of drug transporter database
por: Yin, Jiayi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_oaus8ku4cqkujf0ejjr44g39c2